L&G Pharma Breakthrough UCITS ETF | BIOTRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 31/03/2024 |
|
Annual Returns (GBP) | 31/03/2024 | |||||||
2019 | 2020 | 2021 | 2022 | 2023 | 31/03 | |||
Price Return | 8.32 | 23.17 | -2.96 | 4.42 | -15.32 | -5.62 | ||
+/- Category | -11.88 | -2.80 | 6.07 | 12.25 | -14.04 | -7.92 | ||
+/- Category Index | -8.39 | -9.76 | -3.26 | 1.95 | -22.66 | -14.11 | ||
% Rank in Category | 95 | 33 | 44 | 19 | 93 | 88 |
Trailing Returns (GBP) | 24/04/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.17 | -0.47 | 0.68 |
1 Week | 2.27 | 1.82 | 0.22 |
1 Month | -3.67 | 2.05 | -1.62 |
3 Months | -6.88 | -4.84 | -13.48 |
6 Months | -6.87 | -20.87 | -20.80 |
YTD | -9.60 | -5.63 | -16.00 |
1 Year | -20.82 | -19.50 | -31.18 |
3 Years Annualised | -6.72 | -0.46 | -13.31 |
5 Years Annualised | -0.09 | -5.46 | -12.02 |
10 Years Annualised | - | - | - |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 31/03/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | -5.62 | - | - | - |
2023 | -6.66 | -6.17 | -1.41 | -1.93 |
2022 | -2.07 | -0.96 | 2.66 | 4.87 |
2021 | -6.42 | 6.59 | -0.47 | -2.25 |
2020 | -2.59 | 27.37 | -1.22 | 0.50 |
2019 | 8.91 | -1.47 | -7.41 | 9.02 |
|
Advertisement |